Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vicky Makker
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Maine Medical Center-Bramhall Campus
Portland, Maine, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Sanford Cancer Center-Oncology Clinic
Sioux Falls, South Dakota, United States
- Sanford Nci Community Oncology Research Program of the North Central Plains
Sioux Falls, South Dakota, United States
- Sanford Usd Medical Center - Sioux Falls
Sioux Falls, South Dakota, United States
- Northwest Hospital
Seattle, Washington, United States
- Pacific Gynecology Specialists
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 13 Mar 2018
- Registered enrollment
- 28
- Registry id
- NCT01642082
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.